Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.
2.
3.
4.

Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J.

Am J Physiol Renal Physiol. 2000 Jul;279(1):F130-43.

5.

Vitamin E ameliorates renal fibrosis in ureteral obstruction: role of maintaining BMP-7 during epithelial-to-mesenchymal transition.

Tasanarong A, Kongkham S, Thitiarchakul S, Eiam-Ong S.

J Med Assoc Thai. 2011 Dec;94 Suppl 7:S10-8.

PMID:
22619901
6.

Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat.

Mazzei LJ, García IM, Altamirano L, Docherty NG, Manucha W.

Am J Nephrol. 2012;35(2):103-13. doi: 10.1159/000334935. Epub 2011 Dec 29.

PMID:
22212364
7.

Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function.

Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S.

J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S14-21.

9.

Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats.

Ito K, Chen J, El Chaar M, Stern JM, Seshan SV, Khodadadian JJ, Richardson I, Hyman MJ, Vaughan ED Jr, Poppas DP, Felsen D.

Am J Physiol Renal Physiol. 2004 Dec;287(6):F1283-93. Epub 2004 Aug 24.

10.

CD44v3-v10 reduces the profibrotic effects of TGF-β1 and attenuates tubular injury in the early stage of chronic obstructive nephropathy.

Rampanelli E, Rouschop K, Teske GJ, Claessen N, Leemans JC, Florquin S.

Am J Physiol Renal Physiol. 2013 Nov 15;305(10):F1445-54. doi: 10.1152/ajprenal.00340.2013. Epub 2013 Sep 11.

11.

Urinary tract obstruction.

Klahr S.

Semin Nephrol. 2001 Mar;21(2):133-45. Review.

PMID:
11245776
12.

Sustained-release prostacyclin analog ONO-1301 ameliorates tubulointerstitial alterations in a mouse obstructive nephropathy model.

Nasu T, Kinomura M, Tanabe K, Yamasaki H, Htay SL, Saito D, Hinamoto N, Watatani H, Ujike H, Suzuki Y, Sugaya T, Sugiyama H, Sakai Y, Matsumoto K, Maeshima Y, Makino H.

Am J Physiol Renal Physiol. 2012 Jun 15;302(12):F1616-29. doi: 10.1152/ajprenal.00538.2011. Epub 2012 Mar 14.

13.

HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-β mediated renal fibrosis in obstructive uropathy.

Manson SR, Song JB, Hruska KA, Austin PF.

J Urol. 2014 Jan;191(1):242-52. doi: 10.1016/j.juro.2013.06.110. Epub 2013 Jun 29.

14.

Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta.

Wright EJ, McCaffrey TA, Robertson AP, Vaughan ED Jr, Felsen D.

Lab Invest. 1996 Feb;74(2):528-37.

PMID:
8780170
15.

Recovery following relief of unilateral ureteral obstruction in the neonatal rat.

Chevalier RL, Kim A, Thornhill BA, Wolstenholme JT.

Kidney Int. 1999 Mar;55(3):793-807.

16.

Obstructive uropathy.

Truong LD, Gaber L, Eknoyan G.

Contrib Nephrol. 2011;169:311-26. doi: 10.1159/000314578. Epub 2011 Jan 20.

PMID:
21252529
17.

Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.

Guo G, Morrissey J, McCracken R, Tolley T, Klahr S.

Am J Physiol. 1999 Nov;277(5 Pt 2):F766-72.

18.

Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy.

Zhang G, Kim H, Cai X, López-Guisa JM, Alpers CE, Liu Y, Carmeliet P, Eddy AA.

J Am Soc Nephrol. 2003 May;14(5):1254-71.

19.

Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy.

Gao X, Mae H, Ayabe N, Takai T, Oshima K, Hattori M, Ueki T, Fujimoto J, Tanizawa T.

Kidney Int. 2002 Oct;62(4):1238-48.

20.

Supplemental Content

Support Center